3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Multiple Myeloma
4
Burkitt Lymphoma
3
Neoplasm Metastasis
2
Lymphoma, Large B-Cell, Diffuse
2
Leukemia, Biphenotypic, Acute
2
Thymoma
1
Prostatic Neoplasms
1
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
1
Neoplasms
1
Lymphoma, Follicular
1
Lymphoma, Extranodal NK-T-Cell
1
Lymphoma
1
Lymphohistiocytosis, Hemophagocytic
1
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Hepatectomy
1
Hematologic Neoplasms
1
Brain Neoplasms
1
Blastic Plasmacytoid Dendritic Cell Neoplasm
1
Interventions
Magnetic Resonance Spectroscopy
23
Radiosurgery
21
Temozolomide
14
Bevacizumab
12
pembrolizumab
10
Specimen Handling
9
Nivolumab
8
Radiotherapy
7
Ipilimumab
7
Magnetic Resonance Imaging
6
Cyclophosphamide
5
Capecitabine
5
Blood Specimen Collection
5
encorafenib
4
Radiation
4
Neuropsychological Tests
4
Mental Status and Dementia Tests
4
Memantine
4
Carboplatin
4
fludarabine
3
fluciclovine F-18
3
binimetinib
3
abemaciclib
3
Watchful Waiting
3
Proton Therapy
3
Etoposide
3
Dexamethasone
3
Adrenal Cortex Hormones
3
trastuzumab deruxtecan
2
sacituzumab govitecan
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Brain Neoplasms
×
Methylprednisolone
×
Clear all
NCT05789589
2026-03-04
ADORATION
Baptist Health South Florida
Phase 1/2
Recruiting
46 enrolled